Aier Eye Hospital Group Co., Ltd.

Shenzhen Stock Exchange:300015.SZ

Sector

🏥 Health Care

Industries

🏥 Hospitals & Clinics

🕶 Eyewear

💻 Telehealth

Location

China

Market Cap

USD 16.26 B

Share Price

USD 1.75

Avg Daily Volume

55,312,792

Change (1 day)

0.70%

Change (1 year)

18.41%

Change (YTD)

-3.84%

Aier Eye Hospital Group Co., Ltd. EBITDA for the year ending December 31, 2024: USD 882.58 M

Aier Eye Hospital Group Co., Ltd. EBITDA is USD 882.58 M for the year ending December 31, 2024, a 2.84% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Aier Eye Hospital Group Co., Ltd. EBITDA for the year ending December 31, 2023 was USD 858.20 M, a 26.57% change year over year.
Aier Eye Hospital Group Co., Ltd. EBITDA for the year ending December 31, 2022 was USD 678.02 M, a -3.84% change year over year.
Aier Eye Hospital Group Co., Ltd. EBITDA for the year ending December 31, 2021 was USD 705.12 M, a 52.32% change year over year.
Aier Eye Hospital Group Co., Ltd. EBITDA for the year ending December 31, 2020 was USD 462.91 M, a 32.21% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Shenzhen Stock Exchange: 300015.SZ

Aier Eye Hospital Group Co., Ltd.

CEO	Mr. Bang Chen
IPO Date	Oct. 30, 2009
Location	China
Headquarters	New Century Mansion No. 198
Employees	42,693
Sector	🏥 Health Care
Industries Hospitals & Clinics 🕶 Eyewear 💻 Telehealth

Description

Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions. The company offers medical services in the areas of fundus diseases, optometry, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. The company operates approximately 500 ophthalmic hospitals in mainland China, 86 ophthalmic hospitals in Europe, 1 ophthalmic hospital in the United States, 7 ophthalmic hospitals in Hong Kong, and 12 ophthalmic hospitals in Southeast Asia. The company was founded in 2007 and is headquartered in Changsha, China.